Management of venous thromboembolic (VTE) disease--Part I: Prevention.
Kayser
S R
SR
Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, USA.
D005343:Fibrinolytic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D006493:Heparin / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000517:prevention & control*; D012307:Risk Factors; D013923:Thromboembolism / Q000175:diagnosis / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000175:diagnosis / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D006493:Heparin